Our strategy 2017-2021

15 December 2016

The Danish Medicines Agency: Among Europe’s best in class! This is the title of our strategy for 2017-2021, which emphasises our commitment to both public health and growth in Denmark. The strategy describes a number of focus areas built on the five points of our vision.

”Our strategy is ambitious and has a broad scope. We’ve worked intensively on the strategy over the past couple of months and involved a wide range of our stakeholders and employees. The result is a detailed strategy, and it represents our best estimate of what we believe will be required to make the Danish Medicines Agency one of Europe’s best in class,” says Thomas Senderovitz, Director General of the Danish Medicines Agency.

Read the Danish Medicines Agency’s strategy 2017-2021 (PDF)